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Abstract
Background: It is known that office-hour measurements might not adequately estimate IOP mean, peaks and
fluctuations in healthy subjects. The purpose of the present study is to verify whether office-hour measurements in
patients in different body positions can estimate the characteristics of 24-hour intraocular pressure (IOP) in treated
POAG patients.
Methods: The 24-hour IOP curves of 70 eyes of 70 caucasian patients with treated glaucoma were analyzed.
Measurements were taken at 9 AM; 12, 3, 6, and 9 PM; and 12, 3, and 6 AM, both in the supine (TonoPen XL) and
sitting (Goldmann tonometer) positions. The ability of five strategies to estimate IOP mean, peak and fluctuation
was evaluated. Each method was analyzed both with regression of the estimate error on the real value and with
“hit or miss” analysis.
Results: The least biased estimate of the Peak IOP was obtained using measurements from both supine and sitting
positions, also yielding the highest rate of correct predictions (which was significantly different from 3 of the
remaining 4 strategies proposed, p < 0.05). Strategies obtained from the combination of supine, sitting and peak
measurements resulted to be least biased for the Mean IOP and the IOP Fluctuation estimate, but all strategies
were not found significantly different in terms of correct prediction rate (the only significant difference being
between the two strategies based on sitting or supine measurements only, with the former being the one with
the highest correct prediction rate).
Conclusions: The results of this study remark the concept that IOP is a dynamic parameter and that intensive
measurement is helpful in determining its characteristics. All office-hour strategies showed a very poor performance
of in correctly predicting the considered parameters within the thresholds used in this paper, all scoring a correct
prediction rate below 52 %.
Keywords: Glaucoma, 24-hour IOP, Office-hour IOP, IOP peak and fluctuation, Timolol, Latanoprost, Brimonidine,
Fixed combination timolol dorzolamide
Background
Intraocular pressure (IOP) is the main risk factor for the
development and progression of glaucoma [1–4] and the
only treatable one. IOP parameters (mean, peak and
fluctuation) should be measured at diagnosis and strictly
monitored in order to address the efficacy of IOP-
lowering interventions. Mean IOP has been consistently
recognized as a major risk factor for glaucoma and its
progression [1, 2, 4] whereas the role of peak [5, 6] and
fluctuation [7–12] as independent risk factors is still
controversial.
Many studies report that mean IOP is not signifi-
cantly different when measured during office-hour
and 24-hour [13–16], but that office-hour data may
significantly underestimate IOP peak and fluctuation:
the majority of glaucoma patients had their IOP
peaks outside office hours, most frequently occurring
in night hours [14, 16–19].* Correspondence: leonardo.colombo.82@gmail.com
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In addiction to that supine office hour IOP measure-
ments were described to better estimate IOP peaks than
sitting measurements alone [16].
The most precise procedure to investigate IOP charac-
teristics is 24-hour phasing [13–16, 20, 21] though it is
unpractical, expensive and can be performed in a small
subgroup of patients in few institutions. In addiction to
that, due to the unavailability of IOP-measuring tech-
niques that can be used while the patient sleeps, night-
time evaluations require awakening of patients, potentially
causing artifacts related to stress.
In 2009 the group of Leonardi developed a disposable
contact lens sensor (CLS) that allows continous IOP
monitoring (Sensimed AG, Lausanne, Switzerland) [22].
Nowadays the major limitation of this technology is the
fact that the results of IOP evaluations are not provided
in the habitual mmHg units but in an arbitrary unit and
a direct comparison between the two methods cannot be
performed yet [23].
The difficulty in obtaining 24-hour curves and the
possible discrepancies between 24-hour and office-hour
data led our [14] and other groups [16, 18, 19] to de-
velop strategies to estimate 24-hour parameters by
office-hour data. We showed that the collection of su-
pine and sitting office-hour measurements may enhance
the correct identification of 24-hour IOP characteristics
in both healthy subjects and untreated POAG [14].
The purpose of the present study was to verify whether
office-hour measurements taken in different body posi-
tions can estimate the characteristics of 24-hour IOP in
POAG patients using different IOP-lowering treatments.
Methods
This study was a retrospective analysis of 24-hour IOP
curves of POAG treated patients, collected in the con-
text of clinical trials investigating the circadian effect of
antiglaucoma drugs. It was conducted at the Eye Clinic
of San Paolo Hospital, University of Milan, Italy, after
approval by the local Ethics Committee of San Paolo
Hospital in Milan, and according to the tenets of the
Declaration of Helsinki and national laws for the protec-
tion of personal data. Written informed consent was ob-
tained from all the study participants.
Study population
Seventy caucasian patients were enrolled (39 men and
31 women): 19 of them were treated with timolol (twice
a day), 29 with latanoprost (once a day), ten with brimo-
nidine (twice a day) and 12 with the fixed combination
dorzolamide/timolol (FCDT, twice a day). These treat-
ments options were part of their standard care.
To be included in the study, patients had to have
glaucomatous visual fields (abnormal mean defect and
corrected pattern standard deviation on at least two
consecutive, reliable Humphrey 30–2 full-threshold tests),
optic nerve head (ONH) changes (presence of concentric
enlargement of the optic cup, localized notching, or both,
as evaluated by means of color stereophotographs), and/or
retinal nerve fiber layer (RNFL) defects (presence of focal
or diffuse neuroretinal rim thinning, as evaluated by
means of a scanning laser ophthalmoscope). Patients with
ocular hypertension were excluded. Patients with un-
treated POAG were not included in this study.
Exclusion criteria included angle-closure glaucoma,
secondary glaucomas, corneal abnormalities preventing
reliable IOP measurement, previous filtration surgery,
having one eye, pregnancy, significant disturbances of
wake-sleep rhythms, and/or the regular use of hypnotic
drugs reported by the patients. Eligibility was verified by
means of a complete ophthalmic assessment.
Twenty-four-Hour IOP evaluation
The methodology to assess 24-hour IOP is described in
previous papers [14, 24] and summarized in Fig. 1.
The patients were hospitalized in the morning at
7 AM and stayed for the following 24 h. The awake
period lasted from approximately 6:30 AM to
11:00 PM. IOP was measured at 9 AM; 12,3,6, and
9 PM; and 12, 3 and 6 AM both in the supine and
sitting positions.
For the daytime measurements (9 AM–9 PM), pa-
tients were asked to go to bed and relax for approxi-
mately 15 min, after which supine IOP was measured
in both eyes. After approximately 10 min, a second
IOP value was measured at the slit lamp. During the
night, the patients were awakened approximately
10 min before each measurement to prevent a sudden
increase in IOP. The IOP supine measurements were
taken with a handheld electronic tonometer (TonoPen
XL; Bio-Rad, Glendale, CA); the IOP sitting measure-
ments on the other hand were taken with Goldmann
applanation tonometer at the slit lamp. Every meas-
urement by TonoPen XL consisted of a variable num-
ber of readings until the coefficient of variation was
less than 5 %. All measurements were taken at each
time point by two well-trained glaucoma specialists
who had obtained good accordance between their
measurements (κ = 0.82 with both tonometers). If the
measurements differed by >2 mm Hg, a third meas-
urement was taken; the mean of two or the median
of three recordings was used for the analysis.
Peak IOP estimator strategies
Five parameters were tested in their ability of extrapolat-
ing peak IOP from office-hour readings:
1. The highest value obtained from the office-hour
curve in the sitting position.
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2. The formula proposed by Mosaed et al. 21 based on
office-hour supine IOP (peak IOP = 5.98 + 0.771 +
average office-hour supine IOP).
3. The formula proposed by Mosaed et al. 21 based on
office-hour sitting IOP (peak IOP = 12.04 + 0.616 +
average office-hour sitting IOP).
4. The mean of values obtained with the previous two
formulas.
5. The highest value obtained from the office-hour
curve in both supine and sitting positions.
Mean IOP and IOP fluctuations estimator strategies
The 24-hour mean IOP and IOP fluctuations in habitual
body position were compared to those calculated from:
1. Office-hour readings only in the sitting position
(four measurements).
2. Office-hour readings only in the supine position
(four measurements).
3. Office-hour sitting readings (four measurements) +
the peak IOP, as estimated with the better of the
previous formulas.
4. A combination of sitting and supine office-hour
readings (four + four measurements).
5. A combination of sitting and supine office-hour
readings (four + four measurements) + the estimated
peak IOP.
Statistical analysis
We considered the 24-hour curves obtained in habitual
body position—that is sitting readings during waking
time (from 9 AM to 9 PM) and supine readings during
night time (from 12 to 6 AM). These curves were com-
pared to the readings of the same 24-hour curves ob-
tained during office hours (from 9 AM to 6 PM) in both
supine and sitting positions in order to evaluate the abil-
ity of off-h readings to predict 24-h characteristics.
The following parameters were calculated: mean and
range of the difference between estimate and 24-hour IOP
parameter (expressed as absolute values, i.e., both an
underestimation of −4 mm Hg and an overestimation of
+4 mm Hg counting as 4 mm Hg. Linear models and gen-
eralized linear models were used to assess the quality of
the analyzed estimators. First, we analyzed the relation be-
tween the real value to be estimated and the estimate
error (specifically the difference between the estimate and
the real value). For most of the cases, a linear regression
approach properly modeled the relation between the real
value and the estimate. For two strategies (Strategy 1 for
the peak value and Strategy 1 for the fluctuations) a Zero
Inflated Compound Poisson Model (ZICP) was used to
model the estimate error dependency on the real value
due its peculiar skewed distribution and high zero counts.
A ZICP model can be broken down in two parts: the first
part uses a binomial distribution to model the zero/non
zero outcome of the Estimate Error, while the second part
models the distribution of the continuous Estimate Error
value when not zero.
Next, we adopted a “hit or miss” approach to assess
the error rate of each strategy, considering an estimate
error within ± 2 mmHg as a correct prediction for the
Peak IOP and Mean IOP, ± 1 mmHg for IOP Fluctua-
tions. In this context, a multinomial logit model was
used on the various strategies to assess the odds of over-
estimation, underestimation and correct prediction. For
the two strategies for which the ZICP was used, a com-
pletely correct prediction odds (0 mmHg error) was also
derived from the binomial part of the model.
All numeric predictors (i.e. the real values) were mean
centered, so the intercept corresponds to the estimates
for the mean predictor value.
Fig. 1 24-hour IOP evaluation
Colombo et al. BMC Ophthalmology  (2016) 16:15 Page 3 of 12
Then, an analysis by treatment groups was conducted
to assess differences in estimation. In this case a classical
ANOVA approach was chosen and a post-hoc correction
(Tukey-Kramer) was used for multiple comparisons.
Finally, an overall comparison of the strategies was
performed fitting a logit model for each feature consid-
ered (Mean, Peak and Fluctuation) with the Strategy as
the predictor (where each strategy represented a level)
and “Hit” or “Miss” as the response variable, according
to the above classification of hits or misses. A Subject
random effect was included to account for the fact that
each strategy estimated the same real value for each sub-
ject. Then a post hoc analysis (Tukey-Kramer) was per-
formed to compare the various strategies in terms of
odds of hits or misses.
All calculations were made in R scripting environment.
Results
The mean age was 73.1 ± 9.09 years. 24-hour IOP data
in habitual body position are shown in Table 1.
Mean and peak IOP were lower in patients treated
with latanoprost than in patients treated with timolol
(respectively P = 0.03 and 0.05); significant differences
were not found among the other groups. Differences in
fluctuation between groups were negligible.
IOP peaked outside office hours in 65 % of all patients
(timolol, 58 %; latanoprost, 76 %; brimonidine, 60 %;
FCDT, 58 %).
The analysis focused on the accuracy of predictions
from the various methods tested. Each method was ana-
lyzed both with regression of the estimate error (esti-
mated value – real value) on the real value and with “hit
or miss” analysis. For each of the three variables ana-
lyzed (Mean, Peak and Fluctuation) no significant differ-
ences were found among the treatment groups (p-values
all greater than 0.13, ANOVA).
Regression analysis
Peak estimate
The five strategies presented above were analyzed, in
terms of difference of the estimated value from the cor-
responding real value (Estimate Error). Strategies from 2
to 5 were analyzed using simple regression with Gauss-
ian error distribution using the real Peak IOP value as a
predictor of the Estimate Error. The results are reported
in Table 2. All strategies showed a significant depend-
ency of the Estimate Error on the real Peak value with a
negative slope, i.e. overestimation was more likely for
smaller values and underestimation for larger values.
Strategy 5 showed the smallest slope, yielding the least
biased estimate of the Peak value.
Strategy 1 required a detailed analysis due to its pecu-
liar Estimate Error distribution: only underestimation er-
rors were allowed with a relatively high rate of correct
prediction (zero Estimate Error). To properly model
such negatively skewed distribution with high zero
counts we reversed the sign of the Error and used a
ZICP model. This allowed accurate modeling of the odds
of correct predictions and of the skewed negative errors.
Particularly, the odds of correct prediction did not
depend on the peak value (p-value = 0.3) and was signifi-
cantly different from 1 (odds = 0.52, probability of correct
prediction = 0.34, p-value < 0.01). The mean prediction for
non zero errors was significantly dependent on the real
peak IOP value (p < 0.001) in a non linear fashion, as
depicted in Fig. 2.
Mean estimate
Five strategies for estimating the Mean IOP value were
analyzed as for the Peak strategies. In this case only lin-
ear regression analysis was necessary. Results are pre-
sented in Table 3. Strategies 3 and 4 showed a non
significant dependency on the real Mean IOP value and
a global mean non significantly different from zero (p-
values > 0.05). Strategy 1 and 5 showed a non significant
dependency of the Estimate Error on the Real Mean IOP
but had a significant offset (negative for Strategy 1, posi-
tive for Strategy 5).
Fluctuation estimate
As for the Peak Value, Strategies from 2 to 5 were ana-
lyzed using simple regression with Gaussian error distri-
bution using the real value as a predictor of the estimate
error. The results are reported in Table 4.
As in the Peak estimate, one of the Strategies, specific-
ally Strategy 1, showed a limiting effect to overesti-
mation, yielding a relatively high rate (although much
lower than for Strategy 1 for the Peak value) of correct
Table 1 The 24-hour IOP data in Habitual Body Position
Timing of peaks
Mean ± SD (Range) Peak ± SD (Range) Fluctuation ± SD (Range) During office hours Outside office hours
All patients 18.1 ± 3.4 (11.8–28.9) 22.5 ± 4.1 (15–33) 8.7 ± 2.9 (4–17) 35 % 65 %
Timolol 19.4 ± 3.5 (15.5–28.9) 24 ± 4 (19–33) 9 ± 2.7 (6–16) 42 % 58 %
Latanoprost 17.2 ± 3 (11.8–25.4) 21.7 ± 3.4 (16–29) 8.5 ± 2.7 (4–15) 24 % 76 %
Brimonidine 18.7 ± 3 (15.4–24) 22.5 ± 3,3 (19–28) 8.1 ± 2.2 (4–12) 40 % 60 %
DTFC 17.6 ± 3.9 (13.4–26.2) 22.2 ± 5.7 (15–32) 9 ± 4,3 (4–17) 42 % 58 %
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predictions (zero error) and a negatively skewed error
distribution. Again, this was modeled using a ZICP
model and the odds of correct prediction did not depend
on the real fluctuation value (p-value = 0.60) and was
significantly different from 1 (odds = 0.13, probability of
correct prediction = 0.11, p-value < 0.01). The mean pre-
diction for non zero errors was significantly dependent
on the real IOP fluctuation value (p < 0.001) in a non lin-
ear fashion, as depicted in Fig. 3.
Hit or miss analysis
A second step of the analysis was aimed at the
characterization, for each strategy, of the probability of
yielding clinically reliable estimates of the quantities of
interest. To test this, we chose a rage of clinical toler-
ance (±2 mmHg for the IOP Peak estimate and the
Mean IOP estimate, ± 1 for the IOP Fluctuation
estimate). Errors within the tolerance range were consid-
ered as “Hit”, errors outside the range were counted as
“Miss” (subdivided in overestimates, “Over” and underesti-
mates, “Under”). Then, a multinomial logit model was
used for each strategy to model the “hit or miss”. This ap-
proach had the advantage of allowing a comparison the
different strategies independent of the error distribution.
Hits were used as the reference category, so the model
summary tables (see below) present the logit coefficients
of “Over” versus “Hit” and “Under” versus “Hit”.
Peak strategies
Table 5 shows the results for the multinomial logit
model for IOP Peak strategies. Each model compares
the selected strategy in terms of odds of overesti-
mation or underestimation with respect to correct hits
(within ±2 mmHg). The first Strategy had no “Over”
Table 2 Estimated regression coefficients of the Estimate Error on the real IOP Peak value. In brackets, the standard errors of the
coefficient estimates
Estimate Error
Strategy 2 Strategy 3 Strategy 4 Strategy 5
IOP Peak Coefficient −0.561*** −0.559*** −0.560*** −0.225**
(0.056) (0.045) (0.045) (0.089)
Global Mean −1.858*** 0.389** −0.734*** 0.229
(0.228) (0.181) (0.182) (0.361)
Observations 70 70 70 70
R2 0.594 0.696 0.696 0.086
Adjusted R2 0.588 0.691 0.692 0.072
Residual Std. Error (df = 68) 1.905 1.518 1.520 3.024
F Statistic (df = 1; 68) 99.566*** 155.494*** 155.859*** 6.376**
Asterisks represent the significance level according to the legend in the footnotes
Note: *p < 0.1; **p < 0.05; ***p < 0.01
Fig. 2 Scatterplot for Estimate Error of Strategy 1. Black dots represent the correct estimates (zero error), red dots the incorrect estimates. The
black line represents the prediction from the ZICP model showing the non linear dependency of the non zero error on the real peak value. Note
the skewed distribution around the mean
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since it never overestimated the Peak Value. Strategy 5
resulted to be the most balanced in terms of over and
underestimate and showed no significant (p > 0.05)
relation with the true Peak IOP value (i.e. almost con-
stant error rate) although, as for all the proposed
strategies, overestimate tended to cluster at low peak
values and underestimate at high peak values. Figure 4
shows scatter plots of the estimated values versus the
real values, with misses highlighted in red.
Mean strategies
Table 6 shows the results for the multinomial logit
model for Mean IOP strategies. Each model compares
the selected strategy in terms of odds of overestimation
or underestimation with respect to correct hits (within
±2 mmHg). Strategy 2 showed the highest rate of Over-
estimates, being even higher that correct Hits. Strategy 1
showed the highest Hit rate and no correlation of errors
with the true Mean IOP value. All strategies except for
Strategy 2 showed no significant correlation with the
true Mean IOP value. Figure 5 shows scatter plots of the
estimated values versus the real values, with misses
highlighted in red.
Fluctuation strategies
Table 7 shows the results for the multinomial logit
model for IOP Fluctuation strategies. Each model com-
pares the selected strategy in terms of odds of overesti-
mation or underestimation with respect to correct hits
(within ±mmHg). The strategies with the highest Hit
rate and more balanced Over/Underestimation rate were
Strategy 4 and 5 (which yielded the exact same esti-
mates for all subjects), although showing a strong
correlation with the real IOP fluctuations, especially
for the odds of underestimations, being more likely
for higher Fluctuation value. Figure 6 shows scatter
plots of the estimated values versus the real values,
with misses highlighted in red.
Treatment group analysis
In general, no significant differences were found among
the treatment groups. The only exceptions were for
Strategy 1 for the Peak IOP, where a significant dif-
ference in the Estimate Error was found between the
Brimonidine and the Latanoprost group (Latanoprost
Mean Error = −3.01, Brimonidine Mean Error = −1.4,
p = 0.0105), for Strategy 1 for the IOP Fluctuations,
where a significant difference in the Estimate Error
was found between the Timolol and the Latanoprost
group (Latanoprost Mean Error = −4.41, Timolol
Mean Error = −3.37, p = 0.0045) and for Strategy 3
for the IOP Fluctuations, where a significant differ-
ence in the Estimate Error was found between the
Cosopt and the Latanoprost group (Latanoprost
Mean Error = −1.52, Cosopt Mean Error = −4.33, p =
0.0095). A logit regression model was also calculated
for each Strategy to test differences in Hit/Miss rate
among the treatment groups, but no significant
Table 3 Estimated regression coefficients of the dependent variable (Estimate Error) on the real Mean IOP value
Estimate Error:
Strategy 1 Strategy 2 Strategy 3 Strategy 4 Strategy 5
Mean IOP Coefficient 0.036 −0.226*** 0.034 −0.095* −0.082
(0.052) (0.076) (0.049) (0.052) (0.050)
Global Mean −0.412** 0.978*** 0.288* 0.281 0.593***
(0.175) (0.255) (0.166) (0.175) (0.168)
Observations 70 70 70 70 70
R2 0.007 0.116 0.007 0.047 0.038
Adjusted R2 −0.007 0.103 −0.008 0.033 0.024
Residual Std. Error (df = 68) 1.467 2.134 1.389 1.465 1.406
F Statistic (df = 1; 68) 0.487 8.925*** 0.475 3.376* 2.708
In brackets, the standard errors of the coefficient estimates. Asterisks represent the significance level according to the legend in the footnotes
Note: *p < 0.1; **p < 0.05; ***p < 0.01
Table 4 Estimated regression coefficients of the dependent
variable (Estimate Error) on the real IOP Fluctuation value
Estimate Error
(2) (3) (4) (5)
IOP Fluctuation Coefficient −1.010*** −0.720*** −0.759*** −0.759***
(0.132) (0.097) (0.124) (0.124)
Global Mean −2.100*** −2.714*** −0.200 −0.200
(0.383) (0.281) (0.360) (0.360)
Observations 70 70 70 70
R2 0.462 0.448 0.356 0.356
Adjusted R2 0.454 0.440 0.346 0.346
Residual Std. Error (df = 68) 3.206 2.354 3.008 3.008
F Statistic (df = 1; 68) 58.480*** 55.171*** 37.562*** 37.562***
In brackets, the standard errors of the coefficient estimates. Asterisks represent
the significance level according to the legend in the footnotes
Note: *p < 0.1; **p < 0.05; ***p < 0.01
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difference among treatment groups could be detected
for all strategies.
Hit rate comparison of the strategies
For each considered feature (Peak, Mean and Fluctu-
ations) all strategies were compared in terms of Hits
using a logit model corrected for repeated measures
with a Subject random effect and a post hoc ana-
lysis. For the Peak strategies Strategy 5 yielded the
highest Hit count (37/70) and resulted to be signifi-
cantly different from Strategies 2, 3 and 4 (corrected
p < 0.05). Strategy 1 resulted to be significantly dif-
ferent from Strategy 2 (p = 0.0079) with a higher Hit
count, but not from Strategy 3, 4 and 5 (although
the comparisons with strategies 3 and 4 had low p-
values, respectively 0.11 and 0.07). For the Mean
IOP, only Strategy 1 resulted to be significantly dif-
ferent from Strategy 2 (p = 0.031) but any other dif-
ference was not significant, with Strategy 1 being the
one with the highest Hit count (36/70). No signifi-
cant differences could be found between the Strat-
egies for the IOP Fluctuations, Strategy 4 and 5
being the ones with the highest Hit count (36/70).
Discussion
The results of this study on glaucoma patients treated
with different IOP lowering eye drops remark the
concept that IOP is a dynamic parameter and that in-
tensive measurement is helpful in determining its
characteristics.
Fig. 3 Scatterplot for Estimate Error of Strategy 1. Black dots represent the correct estimates (zero error), red dots the incorrect estimates. The
black line represents the prediction from the ZICP model showing the non linear dependency of the non zero error on the real peak value
Table 5 Estimated logit coefficients from the multinomial logit model (coefficients and standard errors in brackets)
Over/Underestimate logit
Strategy 1 Strategy 2 Strategy 3 Strategy 4 Strategy 5
“Over” at average Peak IOP −1.395 −0.618 −2.117** −0.737**
(0.882) (0.451) (0.844) (0.292)
“Under” at average Peak IOP 0.060 1.486*** −1.441** 0.075 −0.984***
(0.242) (0.475) (0.592) (0.339) (0.324)
“Over” True Value Coefficient −0.295 −0.629*** −0.781*** −0.030
(0.218) (0.176) (0.253) (0.076)
“Under” True Value Coefficient 0.077 0.611*** 0.559*** 0.387*** 0.122
(0.061) (0.171) (0.180) (0.123) (0.076)
Hits 34/70 16/70 21/70 20/70 37/70
Overestimates 0/70 11/70 30/70 19/70 18/70
Underestimates 36/70 43/70 19/70 31/70 15/70
The first two rows report the odds of Overestimates (first row) an Underestimate (second row) with respect to the Hits at the average Peak value. The third and
fourth rows report the logit coefficients for Over and Underestimate for the Peak Value (i.e. how the odds vary with the real Peak value). Asterisks represent the
significance level according to the legend in the footnotes. The second half of the table reports the actual Hits, Over and Underestimate counts for each strategy
Note: *p < 0.1; **p < 0.05; ***p < 0.01
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Fig. 4 Scatter plots of the estimated IOP Peak for each stratgy versus the real IOP Peak. The black line represents the the ideal line of correct
predictions, i.e. estimates exactly equal to the real value. Dashed red lines represents the range of clinical tolerance (±2 mmHg). Black dots
represent the “Hits”, while red dots represent the “Misses”
Table 6 Estimated logit coefficients from the multinomial logit model (coefficients and standard errors in brackets)
Over/Underestimate logit
Strategy 1 Strategy 2 Strategy 3 Strategy 4 Strategy 5
“Over” at average Mean IOP −1.141*** 0.648** −0.408 −0.441 −0.167
(0.346) (0.285) (0.279) (0.282) (0.258)
“Under” at average Mean IOP −0.483* −0.926** −0.776** −0.821*** −1.361***
(0.272) (0.452) (0.313) (0.318) (0.393)
“Over” True Value Coefficient 0.137 0.080 0.104 −0.096 −0.011
(0.095) (0.100) (0.083) (0.092) (0.079)
“Under” True Value Coefficient 0.052 0.355*** 0.070 0.063 0.113
(0.083) (0.126) (0.095) (0.087) (0.102)
Hits 36/70 21/70 33/70 33/70 33/70
Overestimates 12/70 38/70 22/70 22/70 28/70
Underestimates 22/70 11/70 15/70 15/70 9/70
The first two rows report the odds of Overestimates (first row) an Underestimate (second row) with respect to the Hits at the average Mean IOP value. The third
and fourth rows report the logit coefficients for Over and Underestimate for the Mean IOP Value (i.e. how the odds vary with the real Mean IOP value). Asterisks
represent the significance level according to the legend in the footnotes. The second half of the table reports the actual Hits, Over and Underestimate counts for
each strategy
Note: *p < 0.1; **p < 0.05; ***p < 0.01
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Fig. 5 Scatter plots of the estimated Mean IOP for each stratgy versus the real IOP Peak. The black line represents the the ideal line of correct
predictions, i.e. estimates exactly equal to the real value. Dashed red lines represents the range of clinical tolerance (±2 mmHg). Black dots
represent the “Hits”, while red dots represent the “Misses”
Table 7 Estimated logit coefficients from the multinomial logit model (coefficients and standard errors in brackets)
Over/Underestimate logit
Strategy 1 Strategy 2 Strategy 3 Strategy 4 Strategy 5
“Over” at average IOP Fluctuation −2.040*** −3.218*** −0.870** −0.870**
(0.641) (1.098) (0.343) (0.343)
“Under” at average IOP Fluctuation 0.700** −0.214 0.089 −1.329*** −1.329***
(0.277) (0.296) (0.258) (0.426) (0.426)
“Over” True Value Coefficient −0.438* −0.460 −0.109 −0.109
(0.235) (0.356) (0.147) (0.147)
“Under” True Value Coefficient 0.294** 0.470*** 0.248** 0.634*** 0.634***
(0.115) (0.141) (0.102) (0.174) (0.174)
Hits 25/70 32/70 32/70 36/70 36/70
Overestimates 0/70 9/70 3/70 17/70 17/70
Underestimates 45/70 29/70 35/70 17/70 17/70
The first two rows report the odds of Overestimates (first row) an Underestimate (second row) with respect to the Hits at the average Mean IOP value. The third
and fourth rows report the logit coefficients for Over and Underestimate for the Mean IOP Fluctuation value (i.e. how the odds vary with the real IOP Fluctuation
value). Asterisks represent the significance level according to the legend in the footnotes. The second half of the table reports the actual Hits, Over and
Underestimate counts for each strategy
Note: *p < 0.1; **p < 0.05; ***p < 0.01
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Our dataset confirms the critical role of IOP variations
during night hours in glaucoma: IOP peaked outside
office-hour in 65 %, which is similar to 52–66 % of other
studies [13, 19, 25]. This remarks the importance of con-
sidering the 24-hour characteristics of IOP, at least in
critical patients, in order to better tailor treatments to
individual IOP patterns [15].
Different strategies to predict the 24-hour rhythm of
IOP have been reported in literature [14, 16, 18, 19]. In
general, supine IOP is higher than sitting IOP due to in-
creased episcleral venous pressure, and the concept that
supine measurement may be used to predict 24-hour
IOP peak dates 1975 [26].
Correction formulas to predict peak from both sit-
ting [16] and supine [14, 16] measurements have also
been suggested. Water drinking test [27] and ibopa-
mine [28] have also been suggested to predict peak
IOP. The strategy used in this study (a combination of
office-hour supine and sitting measurements) had
been previously used on untreated subjects [14], and
we clearly showed that the relevant 24-hour IOP
characteristics that can be missed by routine examin-
ation (ie office-hour sitting measurements) can be fre-
quently detected when sitting and supine readings are
associated.
When compared to our previous report, this study
seems to suggest that, in general, office hour measure-
ments are not adequate to correctly estimate peak, mean
and fluctuations values within the acceptance thresholds
considered in this paper in treated glaucoma patients.
The best office-hour strategy to estimate the peak IOP
was the combination of sitting and supine office hour
measurements (strategy 5). The error in this strategy
was the least correlated with the real IOP value when
compared with other strategies. In addition it was not af-
fected by a significant mean offset (i.e. yelding the over-
all least biased estimate).
Strategy 1 and 5 were similar in terms of number of
correct peak predictions and resulted not to be signifi-
cantly different upon the correct prediction analysis. It is
important to notice, although, that strategy 1 was greatly
affected by the highly negatively skewed distribution (i.e.
allowed only underestimations) which were not counter-
balanced by the zero error predictions (34 %). From a
clinical point of view this is of particular importance,
showing that sitting office hour measurements tend to
underestimate the correct peak value. This error is not
only significantly correlated with the real Peak IOP
value, but its non linear relation with the real Peak IOP
is difficult to model and to compensate for.
Fig. 6 Scatter plots of the estimated IOP Fluctuations for each stratgy versus the real IOP Peak. The black line represents the the ideal line of
correct predictions, i.e. estimates exactly equal to the real value. Dashed red lines represents the range of clinical tolerance (±1 mmHg). Black dots
represent the “Hits”, while red dots represent the “Misses”
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All office-hour strategies for the Mean IOP esti-
mate, except Strategy 2, showed similar features. The
best strategy in terms of number of correct predic-
tions was sitting office hour measurments alone
(strategy 1), although the odds of correct predictions
were not significantly different from strategies 3, 4
and 5. Strategies 1, 3 and 4 could be considered
equal since no correlation of the errors with the real
values or significant mean offset (i.e. no systematic
bias) could be found; they performed equally in
terms of correct predictions (about 50 %) and the
wrong prediction rate was not correlated with the
real Mean IOP values. Strategy 5 had a significant
mean offset (0.6 mmHg) but this did not affect the
correct prediction rate significantly. Strategy 2 was
the worst both in terms of correct predictions and
in terms of significant systematic bias (especially, ex-
hibited a strong correlation of the errors with the
real Mean IOP value).
The IOP Fluctuation strategies were affected by
several flaws. Strategy 1 performed very poorly in
terms of correct predictions and, as for Strategy 1
for the Peak IOP, suffered from a non linear strong
correlation of the error rate with the real IOP value
and a skewed error distribution, allowing only un-
derestimates. The best in terms of correct predic-
tions were strategies 4 and 5 (which yielded the
same estimates for all subjects) although they were
not significantly different from the other strategies.
All strategies showed a strong correlation of the
error with the real IOP Fluctuation value, underesti-
mating higher values.
As shown in Table 8 using sitting office-hour measure-
ments, a correct identification of all parameters (peak,
mean and fluctuation) was achieved in 24 % of cases,
which was very similar to untreated patients (20 %) [14],
with a slight increased percentage of cases fully charac-
terized adding supine office-hour values (27 %).
The analyses of this study may be prone to a num-
ber of possible limitations that have been previously
described and discussed in details [14]. The accuracy
of 24-hour data may be affected by a number of fac-
tors, including hospitalization, disturbed sleep, sud-
den waking and exposure to light at night [29, 30].
The use of two tonometers could also be a specific
limit of this paper [31, 32]. Still, this 24-hour pro-
cedure is strictly standardized and controlled, and it
has been largely used in our center for nearly two
decades [14, 24, 33–36]. Different characteristics of
the study groups (in particular, baseline IOP) may
largely influence our findings. In fact, we found that
mean 24-hour IOP was higher with timolol than
with others glaucoma medications, thus confirming
previous findings, showing a substantial effect of
timolol during the day, but no measurable effect at
night [24]. Also the choice of timepoints was critical
in determining the results: in particular, latanoprost
patients received their medication after the 9-pm-
measurement, a fact that could explain the high
percentage of IOP peaks outside office-hours. Adher-
ence to treatment was not a concern, as medications
were administered by study personnel during the
study period.
Conclusions
The results of this study remark the concept that
IOP is a dynamic parameter and that intensive meas-
urement is helpful in determining its characteristics.
The methods of this study have been previously used
for untreated subjects, for whom we clearly showed
that relevant 24-hour IOP characteristics may be
missed by routine examination (ie office-hour sitting
measurements), whereas a combination of office-
hour sitting and supine measurements can provide
more accurate information.
The results of this study on treated glaucoma patients
show a very poor performance of all office-hour strat-
egies in correctly predicting the considered parameters
within the thresholds used in this paper, all scoring a
correct prediction rate below 52 %. Some strategies
allowed a simple linear modeling. In these cases a model
to correct for the systematic bias could be theoretically
applicable, but a much larger sample size would be
required for precise parameter estimation. In all cases,
however, the residual standard error was relatively
high (ranging from 1.4 to 3.2) so that a model correc-
tion (i.e. zero mean error) would hardly succeed in
obtaining reliable estimates.
Table 8 The Clinical Impact: Improvement in the
Characterization of the 24-Hour Curve Using Different Criteria
All
patients
Fully characterized by sitting office-hour estimates 24
Fully characterized by sitting + supine office-hour estimates 27
Fully characterized by sitting office-hour estimates + peak
estimation
22
Supine + sitting office hour strategy at least partially
improves office-hour sitting estimates
66
Supine office-hour estimates + peak estimation strategy*




Full characterization: mean IOP, peak, and fluctuations, respectively, within 1,
1, 2 mm Hg from the 24-hour value
Full absence of characterization: mean IOP, peak, and fluctuations,
respectively, outside 1, 1, 2 mm Hg from the
24-hour value
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